Cardiac troponin for the diagnosis of acute coronary syndrome in the emergency department: a review of guidelines
CADTH
Record ID 32014000237
English
Authors' recommendations:
Seven guidelines were retrieved which indicate that cardiac troponin is the preferred biomarker to inform diagnosis of ACS, and recommend that patients presenting to the emergency department have a cardiac troponin test as part of their initial assessment. There is lack of consensus across guidelines regarding the requirements for repeat troponin testing, interval for repeat testing, and the quantification of troponin elevation. Information on the interpretation of borderline elevated cardiac troponin levels was lacking. No Canadian guidelines or recommendations were identified.
Details
Project Status:
Completed
Year Published:
2013
URL for published report:
http://www.cadth.ca/media/pdf/htis/jan-2013/RC0427%20Troponin%20Guidlines%20Final.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Humans
- Emergency Service, Hospital
- Acute Coronary Syndrome
- Troponin
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.